Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMMFYP9)

Drug Name

ME bromodomain inhibitor Drug Info

Synonyms

CHEMBL3769729; Methyl (2r)-2-[(4s)-6-(4-Chlorophenyl)-8-Methoxy-1-Methyl-4h-[1,2,4]triazolo[4,3-A][1,4]benzodiazepin-4-Yl]propanoate; ME bromodomain inhibitor; GTPL7807; SCHEMBL16771925

Indication

Disease Entry	ICD 11	Status	REF
Discovery agent	N.A.	Investigative	[1]

Cross-matching ID

PubChem CID: 86277842
TTD Drug ID: DMMFYP9

Molecule-Related Drug Atlas

Molecule Type:

DTT

Drug Status:

Clinical Trial Drug(s)

Patented Agent(s)

Investigative Drug(s)

Download the Complete Related Drug List

Drug(s) Targeting Bromodomain-containing protein 2 (BRD2)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
OTX-015	DMI8RG1	Acute myeloid leukaemia	2A60	Phase 1/2	[2]
ABBV-744	DMTEA9C	Acute myeloid leukaemia	2A60	Phase 1	[3]
PMID26924192-Compound-104	DM346EU	N. A.	N. A.	Patented	[4]
PMID26924192-Compound-102	DMEJ107	N. A.	N. A.	Patented	[4]
PMID26924192-Compound-103	DMWOCP7	N. A.	N. A.	Patented	[4]
PMID26924192-Compound-105	DMAWLGI	N. A.	N. A.	Patented	[4]
Pyrrolo-pyrrolone derivative 1	DMN4SE5	N. A.	N. A.	Patented	[4]
PMID26924192-Compound-106	DM9HRZJ	N. A.	N. A.	Patented	[4]
XD14	DMUMACD	Discovery agent	N.A.	Investigative	[5]
GW841819X	DMRL9IN	Discovery agent	N.A.	Investigative	[6]
------------------------------------------------------------------------------------


⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Bromodomain-containing protein 2 (BRD2)	TTDP48B	BRD2_HUMAN	Inhibitor	[1]

------------------------------------------------------------------------------------

References

1	Chemical biology. A bump-and-hole approach to engineer controlled selectivity of BET bromodomain chemical probes. Science. 2014 Oct 31;346(6209):638-41.
2	Targeting bromodomains: epigenetic readers of lysine acetylation.Nat Rev Drug Discov.2014 May;13(5):337-56.
3	Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
4	BET inhibitors in cancer therapeutics: a patent review.Expert Opin Ther Pat. 2016;26(4):505-22.
5	4-Acyl pyrroles: mimicking acetylated lysines in histone code reading. Angew Chem Int Ed Engl. 2013 Dec 23;52(52):14055-9.
6	Discovery and characterization of small molecule inhibitors of the BET family bromodomains. J Med Chem. 2011 Jun 9;54(11):3827-38.